Endoscopic Pituitary Surgery: State-of-the-Art & The Cavernous Sinus

San Francisco Neurological Society

J. Fernandez-Miranda

LITT for Deep-Seated Perivascular Brain Tumors: Evaluating the Risk …

Hassan Fadel

How the Neurosurgeon Uniquely Meets the Unmet Need in Today's Precis…

Subcortical Surgery Group

H. Brem

Glioblastoma: How Aggressive to Be?

Ricardo Komotar

WHO 2021 Central Nervous System Tumor Classification (WHO CNS-5)

University of Miami

S. Gultekin

Congenital Neoplasms: Rare, Unique and Poorly Described

UChicago Medicine

L. Baird

Penn Medicine Updates on Brain Tumors

Penn Medicine Abramson Cancer Center

S. Bagley

Primary Brain Tumors: Targeting Metabolism in Glioma

UNC Lineberger Comprehensive Cancer Center

D. Higgins

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

Updates on Glioblastoma

Dana-Farber Cancer Institute

D. Reardon

Overview and Updates in Brain Tumors

Henry Friedman

MIPS in Tumor Applications: Deep Brain Lesions a Review of Current S…

Subcortical Surgery Group

K. Chaichana

GBM Clinical Trials: Early Observations and Future Directions

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

D. O'Rourke

Advances in Immunotherapy for Glioblastoma

San Francisco Neurological Society

O. Bloch

Should We Treat Seizures Associated With Tumors Differently?

Edward Avila

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

New Advances in Minimally Invasive Brain Surgery: What You Need to K…

2020 South Florida Neuroscience Symposium

R. Komotar

Why 5-ALA Fluorescence-Guided Surgery (FGS) for Brain Tumors?

Mount Sinai Fluorescence-Guided Surgery Symposium

C. Hadjipanayis

Surgical Applications: Improving our Understanding of GBM Through Bi…

Subcortical Surgery Group

A. Mohammadi